Sexually active males must use a condom during intercourse while taking the drug(s) and for days after stopping study treatment and should not father a child in this period Sexually active males must use a condom during intercourse while receiving chemoradiation and for days after stopping treatment and should not father a child in this period; a condom is required to be used also by vasectomized men PART GROUP EXCLUSION CRITERIA: Sexually active males unless they use a condom during intercourse while on protocol therapy and for months after study drug discontinuation and thus do not attempt to father a child in this period PART GROUP A EXCLUSION CRITERIA: Sexually active males unless they use a condom during intercourse while on protocol therapy and for months after study drug discontinuation and thus do not attempt to father a child in this period PART GROUP EXCLUSION CRITERIA: Sexually active males unless they use a condom during intercourse while on protocol therapy and for months after study drug discontinuation and thus do not attempt to father a child in this period Sexually active males must use a condom during intercourse while taking drug and for three months after the last dose of the study drug; they should not father a child during this period; men who have undergone vasectomy are also required to use a condom during intercourse Sexually active males unless they use a condom during intercourse while taking the drug and for days after stopping treatment and should not father a child in this period; a condom is required to be used also by vasectomized men Sexually active males unless they use a condom during intercourse Sexually active males unless they use a condom during intercourse while taking drug and for weeks after the last dose of study treatment. Sexually active males who are unwilling to use a condom during intercourse while taking drug and for months after stopping investigational medications and agree not to father a child in this period Sexually active males must be willing to use a condom (even if they have undergone a prior vasectomy) while having intercourse, while taking lenalidomide and for weeks after stopping treatment Sexually active males unless they use a condom during intercourse while taking drug and for months after stopping ceritinib and should not father a child for at least months after the last dose of treatment. Sexually active males unless they are willing to use a condom during intercourse while taking the drug and for days after stopping treatment and are willing to forego fathering a child in this period; a condom is required to be used also by vasectomized men Sexually active males unless they use a condom during intercourse while taking the drug and for days after stopping treatment and should not father a child in this period; a condom is required to be used also by vasectomized men Sexually active males, unless they use a condom during intercourse while taking the drug and for days after stopping treatment; they should not father a child in this period; a condom is required to be used also by vasectomized men Sexually active males unless they use a condom during intercourse while taking the drug and for months after stopping treatment and should not father a child in this period; a condom is required to be used also by vasectomized men Sexually active males must use a condom during intercourse while taking the drugs and for weeks after stopping treatment and should not father a child in this period; a condom is required to be used also by vasectomized men Men who are unwilling to use a condom (even if they have undergone a prior vasectomy) while having intercourse with any woman, while taking the drug and for months after stopping treatment Sexually active males unless they use a condom during intercourse while taking the drug and for months after stopping treatment and should not father a child in this period; a condom is required to be used also by vasectomized men Patients who are not willing to apply highly effective contraception during the study and through the duration of LDE treatment\r\n* Male patients must use highly effective (double barrier) methods of contraception (e.g., spermicidal gel plus condom) for the entire duration of the study, and continuing using contraception and refrain from fathering a child for months following the last dose of the study drug; a condom is also required to be used by vasectomized men as well as during intercourse with a male partner; sexually active males must be willing to use a condom during intercourse while taking the study drug and for months after stopping investigational medications and agree not to father a child during this period Sexually active males unless they use a condom during intercourse while taking the drug and for days after stopping treatment and should not father a child in this period; a condom is required to be used also by vasectomized men Sexually active males, who do not agree to abstinence, must be willing to use a condom during intercourse while taking the study drug, and for weeks after stopping treatment and should not father a child in this period. Sexually active males unless they use a condom during intercourse while taking the drug and for weeks after stopping treatment and should not father a child in this period; a condom is required to be used also by vasectomized men Sexually active males who are unwilling to use a condom during intercourse while taking the study drug and for months after stopping investigational medications and agree not to father a child in this period